Agilent Technologies Total Current Liabilities 2010-2025 | A

Agilent Technologies total current liabilities from 2010 to 2025. Total current liabilities can be defined as the sum of all liabilities classified as current for having maturities of less than one year.
  • Agilent Technologies total current liabilities for the quarter ending April 30, 2025 were $2.012B, a 2.76% increase year-over-year.
  • Agilent Technologies total current liabilities for 2024 were $1.895B, a 18.22% increase from 2023.
  • Agilent Technologies total current liabilities for 2023 were $1.603B, a 13.86% decline from 2022.
  • Agilent Technologies total current liabilities for 2022 were $1.861B, a 8.96% increase from 2021.
Agilent Technologies Annual Total Current Liabilities
(Millions of US $)
2024 $1,895
2023 $1,603
2022 $1,861
2021 $1,708
2020 $1,467
2019 $2,080
2018 $1,171
2017 $1,263
2016 $945
2015 $976
2014 $1,692
2013 $1,602
2012 $1,893
2011 $1,837
2010 $3,083
2009 $1,123
Agilent Technologies Quarterly Total Current Liabilities
(Millions of US $)
2025-04-30 $2,012
2025-01-31 $1,869
2024-10-31 $1,895
2024-07-31 $2,389
2024-04-30 $1,958
2024-01-31 $1,617
2023-10-31 $1,603
2023-07-31 $1,760
2023-04-30 $1,666
2023-01-31 $1,936
2022-10-31 $1,861
2022-07-31 $1,902
2022-04-30 $1,813
2022-01-31 $1,584
2021-10-31 $1,708
2021-07-31 $1,724
2021-04-30 $1,758
2021-01-31 $1,687
2020-10-31 $1,467
2020-07-31 $1,314
2020-04-30 $1,945
2020-01-31 $1,892
2019-10-31 $2,080
2019-07-31 $1,622
2019-04-30 $1,118
2019-01-31 $1,095
2018-10-31 $1,171
2018-07-31 $1,014
2018-04-30 $1,365
2018-01-31 $1,361
2017-10-31 $1,263
2017-07-31 $1,241
2017-04-30 $1,187
2017-01-31 $1,089
2016-10-31 $945
2016-07-31 $1,151
2016-04-30 $1,133
2016-01-31 $947
2015-10-31 $976
2015-07-31 $853
2015-04-30 $930
2015-01-31 $928
2014-10-31 $1,692
2014-07-31 $1,579
2014-04-30 $1,719
2014-01-31 $1,549
2013-10-31 $1,602
2013-07-31 $1,550
2013-04-30 $1,908
2013-01-31 $1,846
2012-10-31 $1,893
2012-07-31 $2,090
2012-04-30 $1,835
2012-01-31 $1,705
2011-10-31 $1,837
2011-07-31 $1,505
2011-04-30 $1,592
2011-01-31 $1,406
2010-10-31 $3,083
2010-07-31 $2,917
2010-04-30 $2,709
2010-01-31 $2,549
2009-10-31 $1,123
2009-07-31 $991
2009-04-30 $1,099
2009-01-31 $1,130
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $34.187B $6.510B
Agilent Technologies, Inc. is an original equipment manufacturer of a broad-based portfolio of test and measurement products serving multiple end markets. Recently, the company has diversified into new end markets, namely industrial, chemical and electronics markets. The company has three business segments, including Life Sciences & Applied Markets Group (LSAG), Diagnostics and Genomics Group (DGG) and Agilent Cross Lab Group (ACG).The company uses a direct sales model for the distribution of its products, which is supplemented by distributors, resellers, manufacturers' representatives, telesales and electronic commerce, as necessary.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $218.593B 25.64
Boston Scientific (BSX) United States $157.132B 37.53
Stryker (SYK) United States $151.401B 31.66
EssilorLuxottica (ESLOY) France $135.007B 0.00
Medtronic (MDT) Ireland $118.404B 16.78
Lonza Group Ag (LZAGY) Switzerland $49.975B 0.00
Haleon (HLN) United Kingdom $44.249B 25.26
ResMed (RMD) United States $40.103B 30.12
GE HealthCare Technologies (GEHC) United States $35.152B 16.69
Terumo (TRUMY) Japan $25.999B 33.77
Koninklijke Philips (PHG) Netherlands $24.882B 17.46
Insulet (PODD) United States $20.168B 79.17
Zimmer Biomet Holdings (ZBH) United States $19.166B 12.31
Baxter (BAX) United States $14.764B 11.02
Smith & Nephew SNATS (SNN) United Kingdom $13.788B 0.00
Sunny Optical Technology (SNPTF) China $10.417B 0.00
Demant (WILYY) Denmark $8.633B 0.00
Bio-Rad Laboratories (BIO) United States $7.131B 24.82
Lantheus Holdings (LNTH) United States $4.907B 12.38
Perrigo (PRGO) Ireland $3.864B 9.79
Prestige Consumer Healthcare (PBH) United States $3.769B 16.84
Haemonetics (HAE) United States $3.568B 16.25
Envista Holdings (NVST) United States $3.503B 29.11
Shandong Weigao Medical Polymer (SHWGF) China $3.459B 0.00
ICU Medical (ICUI) United States $3.180B 23.45
LeMaitre Vascular (LMAT) United States $1.825B 40.79
QuidelOrtho (QDEL) United States $1.781B 12.25
AtriCure (ATRC) United States $1.494B 0.00
Acuren (TIC) United States $1.450B 0.00
Green Thumb Industries (GTBIF) United States $1.268B 28.52
AdaptHealth (AHCO) United States $1.244B 12.63
Phibro Animal Health (PAHC) United States $1.193B 15.25
Neogen (NEOG) United States $1.111B 14.22
BioLife Solutions (BLFS) United States $1.065B 0.00
InMode (INMD) Israel $0.918B 9.25
Kestra Medical Technologies (KMTS) United States $0.871B 0.00
Curaleaf Holdings (CURLF) Canada $0.851B 0.00
Tilray Brands (TLRY) Canada $0.707B 0.00
Maravai LifeSciences Holdings (MRVI) United States $0.690B 0.00
Valneva SE (VALN) France $0.646B 0.00
Evolus (EOLS) United States $0.622B 0.00
Owens & Minor (OMI) United States $0.613B 5.09
CeriBell (CBLL) United States $0.556B 0.00
ZimVie (ZIMV) United States $0.522B 23.71
Surmodics (SRDX) United States $0.458B 0.00
SNDL (SNDL) Canada $0.405B 0.00
Sanuwave Health (SNWV) United States $0.315B 0.00
SEMPERIT AG HLD (SEIGY) Austria $0.314B 0.00
VAREX IMAGING (VREX) United States $0.311B 11.44
Cresco Labs (CRLBF) United States $0.311B 0.00
Capricor Therapeutics (CAPR) United States $0.296B 0.00
Quanterix (QTRX) United States $0.275B 0.00
Aurora Cannabis (ACB) Canada $0.271B 80.17
Cerus (CERS) United States $0.260B 0.00
Viemed Healthcare (VMD) United States $0.249B 20.97
OraSure Technologies (OSUR) United States $0.248B 0.00
Sanara MedTech (SMTI) United States $0.228B 0.00
Canopy Growth (CGC) Canada $0.228B 0.00
Biote (BTMD) United States $0.228B 6.40
Brainsway (BWAY) Israel $0.224B 59.20
Omeros (OMER) United States $0.210B 0.00
Verano Holdings (VRNOF) United States $0.203B 0.00
Organigram Global (OGI) Canada $0.202B 0.00
High Tide (HITI) Canada $0.192B 0.00
Utah Medical Products (UTMD) United States $0.189B 15.52
TriSalus Life Sciences (TLSI) United States $0.177B 0.00
Vireo Growth (VREOF) United States $0.163B 0.00
Exagen (XGN) United States $0.154B 0.00
FitLife Brands (FTLF) United States $0.125B 15.34
TerrAscend (TSNDF) Canada $0.123B 0.00
MacroGenics (MGNX) United States $0.112B 0.00
Jin Medical (ZJYL) China $0.104B 0.00
Fonar (FONR) United States $0.098B 12.70
Quipt Home Medical (QIPT) United States $0.095B 0.00
Jushi Holdings (JUSHF) United States $0.092B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.091B 0.00
Apyx Medical (APYX) United States $0.090B 0.00
Veru (VERU) United States $0.088B 0.00
Safety Shot (SHOT) United States $0.085B 0.00
Zynex (ZYXI) United States $0.077B 0.00
InterCure (INCR) Israel $0.070B 0.00
Agape ATP (ATPC) $0.069B 0.00
Cytosorbents (CTSO) United States $0.063B 0.00
ImmuCell (ICCC) United States $0.061B 0.00
United-Guardian (UG) United States $0.043B 14.92
Modular Medical (MODD) United States $0.039B 0.00
Rockwell Medical (RMTI) United States $0.038B 0.00
Nephros (NEPH) United States $0.036B 49.14
Allurion Technologies (ALUR) United States $0.022B 0.00
INLIF (INLF) $0.015B 0.00
Flora Growth (FLGC) United States $0.014B 0.00
Senestech (SNES) United States $0.013B 0.00
Trinity Biotech (TRIB) Ireland $0.013B 0.00
Meihua Medical Technologies (MHUA) China $0.012B 0.00
IM Cannabis (IMCC) Canada $0.012B 0.00
Cellectar Biosciences (CLRB) United States $0.010B 0.00
Innovative Eyewear (LUCY) United States $0.006B 0.00
Sharps Technology (STSS) United States $0.006B 0.00
GlucoTrack (GCTK) United States $0.004B 0.00
Akanda (AKAN) Canada $0.002B 0.00
InVivo Therapeutics Holdings (NVIVQ) United States $0.000B 0.00